AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Have a cold? Fever? Sinus infection? Your primary-care provider might not give you a prescription for an antibiotic. Here's ...

Ramakrishnan, a distinguished structural biologist and Nobel Laureate in Chemistry (2009), is renowned for his groundbreaking ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization.

Large language models are advancing peptide antibiotic design, identifying patterns in biological sequences to combat ...

Scientists develop self-propelling nanoparticles that can physically pierce and eliminate drug-resistant bacteria in eye infections, showing success in initial animal studies.

A recent study by a team from Chiba University has demonstrated a promising approach for fighting antibiotic resistance by identifying a compound, V-161, that inhibits a sodium-pumping enzyme critical ...

The OECD report highlighted the need for targeted policies to reduce the impact of AMR and noncommunicable diseases and ...

Dr. Melissa Webby of the University of Warwick has received a £2.2 million Wellcome Career Development Award to research the mechanisms that pro ...

Alan W. Dunton, MD, Chief Medical Advisor of Recce Pharmaceuticals, added, "We are thrilled to see such robust clinical ...

Glox Therapeutics Ltd. has been awarded a share of a £3 million (US$3.7 million) collaborative discovery program launched by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) syndicate. The ...